Ireland’s generics and biosimilars industry must be included as a key stakeholder in the next National Medicine Supply and Pricing Agreement with the country’s government, off-patent body Medicines for Ireland has urged.
In a report published today – coinciding with the association’s inaugural “generic medicines day” – the association set...




